OpenVSafe by OpenVAERS
Search V-safe

N26-22246-91022

2 vaccinations 3 coded responses 15 check-ins 1 free-text entry 2 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
303 / GA
Registered
2022-10-20
Relationship
Child or adolescent in my care
Guardian
MVY-19753-97817
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2564556 (opens in a new window) high 11 / 11 — 3 of 6 VAERS symptoms same dose (2) GA matches 2022-10-20 / 2022-12-26 / 2023-01-20
received 91 days before the last call
 case 556150

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2022-09-29
    Dose 1 — Pfizer-BioNTech
    Co-administered: Flu:Hib:Pneumonia:Polio:Rotavirus:Tetanus
  2. 2022-10-20
    Registered in v-safe
  3. 2022-10-20
    Dose 2 — Pfizer-BioNTech
  4. 2022-10-20
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-10-21
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  6. 2022-10-22
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-10-23
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-10-24
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-10-25
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-10-26
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-10-27
    Survey response — day 7, dose 2, under 3
    MedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: Fair · Fever
    Free text: Runny nose (probably a cold)
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-11-03
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-11-10
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-11-17
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-11-24
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  16. 2022-12-03
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2023-01-19
    Survey response — 3 months, dose 2, under 3
    MedDRA: COVID-19, Croup infectious, Hospitalisation — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11
  18. 2023-01-19
    Report sent to call center — 3 months, dose 2, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  19. 2023-01-20
  20. 2023-01-20
  21. 2023-01-20
    Call successful
    Completed over the phone
  22. 2023-04-20
    Survey response — 6 months, dose 2, under 3
    MedDRA: Croup infectious, Cyanosis, Emergency care, Pyrexia, Stridor — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    MedDRA releases: 2024-11
  23. 2023-04-20
    Report sent to call center — 6 months, dose 2, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  24. 2023-04-21
    Call successful
    Reported to VAERS during previous contact from GDIT

Vaccinations

DoseDateManufacturerCo-administered
12022-09-29Pfizer-BioNTech Flu:Hib:Pneumonia:Polio:Rotavirus:Tetanus
22022-10-20Pfizer-BioNTech No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 12 (Under 3) — day 7, dose 2, under 3

2022-10-27

Systemic reaction (other): Runny nose (probably a cold)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDCroup infectious · · ✓
SDCyanosis · · ✓
SDEmergency care · · ✓
SDHospitalisation · · ✓
SDPyrexia · · ✓
SDStridor · · ✓
SRONasopharyngitis · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…